Fulphila (pegfilgrastim)

pCPA File Number: 22737
Negotiation Status:
Concluded with an LOI
Indication(s):
Febrile neutropenia in non-myeloid malignancies
Sponsor/Manufacturer:
Biocon Biologics Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: